Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.

@article{Dean2008MacrophagespecificM,
  title={Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.},
  author={Richard A. Dean and Jennifer H. Cox and Caroline L. Bellac and Alain Doucet and Amanda E Starr and Christopher M. Overall},
  journal={Blood},
  year={2008},
  volume={112 8},
  pages={
          3455-64
        }
}
Through the activity of macrophage-specific matrix metalloproteinase-12 (MMP-12), we found that macrophages dampen the lipopolysaccharide (LPS)-induced influx of polymorphonuclear leukocytes (PMNs)-thus providing a new mechanism for the termination of PMN recruitment in acute inflammation. MMP-12 specifically cleaves human ELR(+) CXC chemokines (CXCL1, -2, -3, -5, and -8) at E-LR, the critical receptor-binding motif or, for CXCL6, carboxyl-terminal to it. Murine (m) MMP-12 also cleaves mCXCL1… 
View on PubMed
bloodjournal.org
229 Citations
Highly Influential Citations
10
Background Citations
88
Methods Citations
3
Results Citations
3

Figures from this paper

229 Citations

Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a key role in modulating myelopoiesis, immune suppression, and lung tumorigenesis.

In vitro and in vivo studies showed an immunosuppressive function on T-cell proliferation and function by CD11b(+)/Gr-1(+) immature cells from MMP12-overexpressing bitransgenic mice.

Biochemical Characterization and N-terminomics Analysis of Leukolysin, the Membrane-type 6 Matrix Metalloprotease (MMP25)

Biochemically characterized MT6-MMP, profiled its tissue inhibitor of metalloproteinase inhibitory spectrum, performed degradomics analyses, and screened 26 chemokines for cleavage using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry to indicate a role for clearance of apoptotic neutrophils.

New insights into the substrate specificity of macrophage elastase MMP-12

Four series of fluorogenic peptide substrates were synthesized based on the sequences of MMP-12 cleavage sites in its known substrates, indicating that the C-terminal hemopexin domain influences substrate binding and/or catalysis.

Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation.

It is postulated that PLA2 activation is induced by chemokines, whose ability to signal inflammation is regulated in a tissue-specific fashion by MMPs, and genetic and pharmacologically induced MMP-deficiencies can be expected to perturb PLA2-mediated inflammatory mechanisms.

Investigation of the Production, Distribution, and Trafficking of MMP-9 in Classically Activated Macrophages

A functional contribution of stable MTs in the enhanced trafficking of MMP-9 extracellularly is demonstrated, and it is shown that heterogeneity exists in macrophage cell populations with respect to M MP-9 production.

The multiple faces of CCL13 in immunity and inflammation

It is suggested that blocking the actions of CCL13 can serve as a novel strategy for the generation of agents with anti-inflammatory activity.

Macrophage matrix metalloproteinase-12 dampens inflammation and neutrophil influx in arthritis.

Moonlighting matrix metalloproteinase substrates: Enhancement of proinflammatory functions of extracellular tyrosyl-tRNA synthetase upon cleavage

The proinflammatory activity of YRS is enhanced by MMP cleavage, which is suggested to form a feed-forward mechanism to promote inflammation.

Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16*

This study reveals for the first time that MMPs activate the long amino-terminal chemokines CCL15 and CCL23 to potent forms that have potential to increase monocyte recruitment during inflammation.

A model of GAG/MIP-2/CXCR2 interfaces and its functional effects.

There is no difference in neutrophil recruitment between wild-type MIP-2 and mutants in the peritoneum, but all activity of the mutants is lost in the lung, supporting the concept that GAG regulation of chemokines is tissue-dependent.
...

References

SHOWING 1-10 OF 53 REFERENCES

Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.

It is proposed that MMPs have an important role in modulating inflammatory and immune responses by processing chemokines in wound healing and in disease.

Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1*

The N-terminal processing of the CXC chemokines stromal cell-derived factor (SDF)-1α and β by MMP-2 is reported, suggesting that MMPs may be important regulatory proteases in attenuating SDF-1 function and point to a deep convergence of two important networks, chemokine and M MPs, to regulate leukocytic activity in vivo.

Matrix Metalloproteinase Processing of CXCL11/I-TAC Results in Loss of Chemoattractant Activity and Altered Glycosaminoglycan Binding*

Results reveal potential new roles in down-regulating Th1 lymphocyte chemoattraction through MMP processing of CXCL11 and highlight an unexpected site for receptor interaction and that the carboxyl terminus is critical for glycosaminoglycan binding, an essential function for the formation of chemokine gradients in vivo.

Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.

A better understanding of regulator (IL-8) and effector molecules (gelatinase B) of neutrophils and of mechanisms underlying leukocytosis, shock syndromes, and stem cell mobilization by IL-8 is led to.

LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity

The identification of matrix metalloproteinase (MMP)-8, the polymorphonuclear (PMN) leukocyte collagenase, as a critical mediator initiating lipopolysaccharide (LPS)-responsiveness in vivo identifies MMP-8 as a key mediator in the regulation of innate immunity.

Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.

The differential receptor usage of the structurally related ELR+ CXC chemokines GCP-2 and ENA-78 is indicative of a different role in inflammatory reactions.

Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release.

Findings suggest that, acutely, MMP-12 mediates smoke-induced inflammation by releasing TNF-alpha from macrophages, with subsequent endothelial activation, neutrophil influx, and proteolytic matrix breakdown caused by neutrophile-derived proteases.

Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10.

A stimulus-dependent role of resident MCs inChemokine production and the existence of a regulatory loop between endogenous IL-10 and the chemokine-mediated cellular component of acute inflammation are proposed.

Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration

These studies reveal additive neuropathogenic properties exerted by a proteolytically cleaved chemokine as consequences of a change in receptor specificity, culminating in neurodegeneration.

Macrophage elastase (MMP-12): a pro-inflammatory mediator?

The instillation of a recombinant form of human MMP-12 in mouse airways induced a severe inflammatory cell recruitment characterized by an early accumulation of neutrophils correlated with an increase in proinflammatory cytokines and in gelatinases and indicated that the model could mimic some of the inflammatory features observed in COPD patients and could be used for the pharmacological evaluation of new anti-inflammatory treatment.
...